Iq-ai Share Discussion Threads

[festario] 14/3/2022 14:34

Yeah, like that makes any sense.

[bad gateway] 14/3/2022 12:43

Probably thinks he's thrown enough in after the last 5p placing.
Sincerely hope he moves to profit soon.

"Trevor Brown, CEO of IQ-AI, has subscribed £150,000 for 3,000,000 Placing Shares in the Placing. Following completion of the Placing, Trevor Brown will be interested in 52,813,236 Ordinary Shares, representing approximately 28.94 per cent of the Company's enlarged issued ordinary share capital."

[festario] 14/3/2022 12:37

If we are embarking on such an exciting journey, one wonders why Trevor Brown is buying shares in that other piece of garbage, BRH, rather than investing in this supposed good thing?

[spurs90] 11/3/2022 19:40

An exciting journey begins...
@gbmfoundation

@NBTStweets

@theABTA

@CancerSupportHQ

@CancerHopeNet

@TBCGBrainCancer

@curemotive

@IvyFoundation

@AlMusella

[festario] 11/3/2022 09:50

So... some welcome blue, incoming.

[festario] 11/3/2022 09:49

4.5p to sell 200k, thats above advertised mid price.

[festario] 10/3/2022 12:34

It looked like a little momentum about to start earlier, with the bid moving to an enormous 4.5pBut the usual sell off and dumping of 100k blocks put paid to it.Same as it ever was.

[rock star] 09/3/2022 19:41

Getting too small to be listed.

[festario] 09/3/2022 15:38

Muted reaction to the RNS launching the Phase 1 trial for the new brain tumour oral drug.

[festario] 07/3/2022 14:57

If only all these accolades would translate into some purchasing of shares in this business eh?

[spurs90] 07/3/2022 14:50

Panel of International Experts Deem MR DSC Perfusion as Most Clinically Validated

MILWAUKEE, WI / ACCESSWIRE / March 7, 2022 / Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, (OTCQB:IQAIF) (LSE:IQAI), is pleased to announce the publication of a review authored by International scientists about the use of advanced MRI techniques in Europe.

The paper, published in Frontiers in Oncology, was written by a team of clinicians, engineers, and physicists working on behalf of the European Cooperation in Science and Technology (COST) Glioma MR Imaging 2.0 (GLiMR) Initiative. It consisted of a comprehensive review of advanced MRI techniques used in Europe for monitoring treatment response in high-grade brain tumors. The authors of the study concluded that dynamic susceptibility contrast (DSC) MRI is the most proven of all advanced methods. IB's software modules, IB Neuro™ and IB DCE™, provided solutions for analysis of this data, with examples from each included in the paper.

The study acknowledged the limitations and challenges presented with conventional MRI and specifically noted the quantitative technology contained in IB Neuro termed "standardization." This exclusive technology is built into IB Neuro and automatically generates standardized relative cerebral blood volume (sRCBV) maps. And, as the paper cites, IB Neuro's sRCBV has demonstrated greater consistency and improved repeatability over the inherently variable and manual "tissue normalization" approaches.

"Standardization is significant because it allows for direct comparison between scans independent of MR scanner platform, field strength, or patient," said Michael Schmainda, CEO of IB. "This paper nicely summarizes the advancements made over the years in advanced MRI techniques, and we are pleased that the sRCBV technology available in IB Neuro was highlighted."

[chesty1] 07/3/2022 08:58

Where is Master with his charts of wisdom then.....

[festario] 04/3/2022 15:54

One day without this falling.Small mercies eh?

[festario] 01/3/2022 11:02

Chart starting to look like capitulation.

[festario] 25/2/2022 10:42

Yes, BRH is garbage, but sadly this is my biggest holding, more fool me.

[pugugly] 25/2/2022 10:41

Not a good day for TB - Two of the companies where he is involved have made page one of the top list "fallers"

[bad gateway] 24/2/2022 08:38

Why would the market need to be informed that the warrants hadn't been taken up? SP's been nowhere near high enough for anyone to expect them to have been surely?
Pretty poor comms on the upcoming trial though. That is a negative imo.

[festario] 24/2/2022 08:35

Is that all we have left here? prayer?

[rock star] 24/2/2022 08:34

Praying for news before results in 2 months.

[festario] 15/2/2022 12:53

Wow, dumping below 5p now.This looks very, very bleak now.The warrants being taken up at 7.5p is a distant memory. A FIFTY percent rise needed for that to even be considered.Not that this company ever designed to inform the market that the warrants weren't taken up.This is LSE, not AIM, and it is shockingly bad corporate governance.